Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response

Immunology Letters

Volumn 145, Issue 1-2, 2012, Pages 10-14

  Gouwy, Mieke ^a   Schiraldi, Milena ^b   Struyf, Sofie ^a   Van Damme, Jo ^a   Uguccioni, Mariagrazia ^b  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

Chemokine receptors; Heterodimers; Leukocyte; Migration; Signalling; Synergy

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; HETERODIMER;

ARTICLE; DIMERIZATION; HUMAN; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84862229464     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.04.005     Document Type: Review

References (43)

1. Martinon F., Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005, 26:447-454.
2. O'Neill L.A.J. Synergism between NOD-like receptors and Toll-like receptors in human B lymphocytes. J Leukoc Biol 2011, 89:173-195.
3. Gouwy M., Struyf S., Proost P., Van Damme J. Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Rev 2005, 16:561-580.
4. Koenen R.R., von Hundelshausen P., Nesmelova I.V., Zernecke A., Liehn E.A., Sarabi A., et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 2009, 15:97-103.
5. Venetz D., Ponzoni M., Schiraldi M., Ferreri A.J., Bertoni F., Doglioni C., et al. Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Int J Cancer 2010, 127:2300-2312.
6. Fernando H., Chin C., Rösgen J., Rajarathnam K. Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor. J Biol Chem 2004, 279:36175-36178.
7. Springael J.Y., Urizar E., Parmentier M. Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev 2005, 16:611-623.
8. Johnson Z., Proudfoot A.E., Handel T.M. Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev 2005, 16:625-636.
9. Thelen M., Muñoz L.M., Rodríguez-Frade J.M., Mellado M. Chemokine receptor oligomerization: functional considerations. Curr Opin Pharmacol 2010, 10:38-43.
10. Struyf S., Proost P., Lenaerts J.P., Stoops G., Wuyts A., Van Damme J. Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, regakine-1. Blood 2001, 97:2197-2204.
11. Struyf S., Stoops G., Van Coillie E., Gouwy M., Schutyser E., Lenaerts J.P., et al. Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants. Biochemistry 2001, 40:11715-11722.
12. 2 -terminal structure. Mol Pharmacol 2002, 62:173-180.
13. Gouwy M., Struyf S., Catusse J., Proost P., Van Damme J. Synergy between pro-inflammatory ligands of G protein-coupled receptors in neutrophil activation and migration. J Leukoc Biol 2004, 76:185-194.
14. Struyf S., Gouwy M., Dillen C., Proost P., Opdenakker G., Van Damme J. Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue. Eur J Immunol 2005, 35:1583-1591.
15. Gijsbers K., Gouwy M., Struyf S., Wuyts A., Proost P., Opdenakker G., et al. GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors. Exp Cell Res 2005, 303:331-342.
16. Gouwy M., Struyf S., Noppen S., Schutyser E., Springael J.Y., Parmentier M., et al. Synergy between co-produced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol Pharmacol 2008, 74:485-495.
17. Gouwy M., Struyf S., Verbeke H., Put W., Proost P., Opdenakker G., et al. CC chemokine ligand-2 synergizes with the nonchemokine G protein-coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8. J Leukoc Biol 2009, 86:671-680.
18. Gouwy M., Struyf S., Berghmans N., Vanormelingen C., Schols D., Van Damme J. CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection. Eur J Immunol 2011, 41:963-973.
19. + cells. J Immunol 2009, 183:7478-7488.
20. Krug A., Uppaluri R., Facchetti F., Dorner B.G., Sheehan K.C.F., Schreiber R.D., et al. Cutting edge: IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol 2002, 169:6079-6083.
21. Vanbervliet B., Bendriss-Vermare N., Massacrier C., Homey B., de Bouteiller O., Brière F., et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 2003, 198:823-830.
22. Meller S., Lauerma A.I., Kopp F.M., Winterberg F., Anthoni M., Müller A., et al. Chemokine responses distinguish chemical-induced allergic from irritant skin inflammation: memory T cells make the difference. J Allergy Clin Immunol 2007, 119:1470-1480.
23. Iellem A., Mariani M., Lang R., Recalde H., Panina-Bordignon P., Sinigaglia F., et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001, 194:847-853.
24. Bai Z., Hayasaka H., Kobayashi M., Li W., Guo Z., Jang M.H., et al. CXC chemokine ligand 12 promotes CCR7-dependent naive T cell trafficking to lymph nodes and Peyer's patches. J Immunol 2009, 182:1287-1295.
25. Baltus T., Weber K.S., Johnson Z., Proudfoot A.E., Weber C. Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 2003, 102:1985-1988.
26. Nesmelova I.V., Sham Y., Gao J., Mayo K.H. CXC and CC chemokines form mixed heterodimers: association free energies from molecular dynamics simulations and experimental correlations. J Biol Chem 2008, 283:24155-24166.
27. Koenen R.R., Weber C. Therapeutic targeting of chemokine interactions in atherosclerosis. Nat Rev Drug Discov 2010, 9:141-153.
28. Nesmelova I.V., Sham Y., Dudek A.Z., van Eijk L.I., Wu G., Slungaard A., et al. Platelet factor 4 and interleukin-8 CXC chemokine heterodimer formation modulates function at the quaternary structural level. J Biol Chem 2005, 280:4948-4958.
29. von Hundelshausen P., Koenen R.R., Sack M., Sebastian F.M., Adriaens W., Proudfoot A.E., et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2005, 150:924-930.
30. Paoletti S., Petkovic V., Sebastiani S., Danelon M.G., Uguccioni M., Gerber B.O. A rich chemokine environment strongly enhances leukocyte migration and activities. Blood 2005, 105:3405-3412.
31. Sebastiani S., Danclon G., Gerber B., Uguccioni M. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first β-strand of chemokine. Eur J Immunol 2005, 35:746-756.
32. Kuscher K., Danelon G., Paoletti S., Stefano L., Schiraldi M., Petkovic V., et al. Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes. Eur J Immunol 2009, 39:1118-1128.
33. Mellado M., Rodriguez-Frade J.M., Vila-Coro A.J., Fernandez S., Martin de Ana A., Jones D.R., et al. Chemokine receptor homo- or hetero-dimerization activates distinct signaling pathways. EMBO J 2001, 20:2497-2507.
34. El-Asmar L., Springael J.Y., Ballet S., Andrieu E.U., Vassart G., Parmentier M. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol Pharmacol 2005, 67:460-469.
35. Contento R.L., Molon B., Boularan C., Pozzan T., Manes S., Marullo S., et al. CXCR4-CCR5: a couple modulating T cell functions. Proc Natl Acad Sci USA 2008, 105:10101-10106.
36. Muñoz L.M., Lucas P., Navarro G., Checa A., Franco R., Martinez-A C., et al. Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. J Immunol 2009, 183:7337-7346.
37. Isik N., Hereld D., Jin T. Fluorescence resonance energy transfer imaging reveals that chemokine-binding modulates heterodimers of CXCR4 and CCR5 receptors. PLoS One 2008, 3:e3424.
38. Dickenson J.M., Hill S.J. Interactions between adenosine A1- and histamine H1-receptors. Int J Biochem 1994, 26:959-969.
39. Sohy D., Parmentier M., Springael J.Y. Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J Biol Chem 2007, 282:30062-30069.
40. Sohy D., Yano H., de Nadai P., Urizar E., Guillabert A., Javitch J.A., et al. Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of selective antagonists. J Biol Chem 2009, 284:31270-31279.
41. Stanford M.M., Issekutz T.B. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo. J Leukoc Biol 2003, 74:791-799.
42. Zwijnenburg P.J., Polfliet M.M., Florquin S., van den Berg T.K., Dijkstra C.D., van Deventer S.J., et al. KC and macrophage inflammatory protein-2 (MIP-2) synergistically induce leukocyte recruitment to the central nervous system in rats. Immunol Lett 2003, 85:1-4.
43. Schiraldi M., Raucci A., Martínez Muñoz L., Livoti E., Celona B., Venereau E., et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012, 209:551-563.